Quantification of Chest Wall Changes After Nuss Bar Removal Utilizing Three-dimensional Optical Surface Scans (CHEST)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jean Daemen
- Phone Number: +31884597777
- Email: j.daemen@zuyderland.nl
Study Locations
-
-
Limburg
-
Heerlen, Limburg, Netherlands, 6419PC
- Zuyderland Medical Centre
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients that received 1 or more Nuss bar(s) to treat pectus excavatum and is/are scheduled to be removed due to the end of treatment.
Exclusion Criteria:
- Patients in which the Nuss bar(s) or its stabilizers are or have been dislocated.
- Patients that received a second operation to treat any complications regarding the initial Nuss bar implantation.
- Patients with proven connective tissue diseases (e.g. Marfan's syndrome).
- Patients with a diagnosis of epilepsy (as the 3D scanner utilizes flashing light to acquire the torso topography)
- Patients that are not fit to remain in a standing position with their arms above shoulder level for a maximum of 60 seconds.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 3D scan arm
This is a single arm study.
Patients in this arm will receive a 3D scan just prior to, 2 weeks after, as well as 6 and 12 months after Nuss bar removal.
|
A 3D optical surface scan is acquired utilizing a handheld 3D scanner.
Such a scanner is comparable to an ordinary photo camera, however, it also records depth.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean change in distance
Time Frame: Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months
|
The mean distance of thoracic wall changes
|
Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months
|
|
Maximum change in distance
Time Frame: Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months
|
The maximum distance of thoracic wall changes
|
Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months
|
|
Volumetric changes
Time Frame: Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months
|
The volumetric chest wall changes
|
Changes from baseline (prior to surgery) to the situation 2 weeks after surgery, as well as after 6 and 12 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Predictors of chest wall changes
Time Frame: Changes in volume, mean and maximum distance from baseline to 12 months
|
Predictors of chest wall changes, assessed by multivariate analysis.
|
Changes in volume, mean and maximum distance from baseline to 12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- METCZ20190103
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.